NPI: 1508834318 · TAVARES, FL 32778 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/08/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/08/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,493 | $1.49M |
| 2019 | 17,247 | $2.37M |
| 2020 | 23,782 | $3.79M |
| 2021 | 17,165 | $1.37M |
| 2022 | 12,093 | $1.41M |
| 2023 | 4,709 | $476K |
| 2024 | 998 | $16K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 31,317 | 1,265 | $4.30M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,518 | 1,749 | $3.26M |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,717 | 1,022 | $1.49M |
| A4657 | Syringe, with or without needle, each | 2,570 | 1,446 | $495K |
| 83540 | 1,772 | 1,259 | $208K | |
| 82728 | 1,755 | 1,250 | $206K | |
| 83550 | 1,706 | 1,211 | $205K | |
| 85041 | 1,571 | 1,101 | $202K | |
| 85048 | 1,559 | 1,094 | $202K | |
| 83970 | 1,396 | 819 | $163K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,020 | 232 | $124K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 230 | 122 | $36K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 151 | 100 | $20K |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 167 | 134 | $19K |
| G0008 | Administration of influenza virus vaccine | 19 | 15 | $4K |
| 90674 | 19 | 15 | $4K |